Tags : MGMT-Unmethylated Glioblastoma Multiforme

BMS Report Results of Opdivo + Radiation in P-III CheckMate

Shots: The P-III CheckMate -498 study involves assessing of Opdivo (nivolumab) + radiation vs temozolomide + radiation in patients with newly diagnosed O6- MGMT-unmethylated GBM The P-III CheckMate -498 (NCT02617589) study demonstrated that it did not meet its 1EPs i.e, OS and is safe for solid tumors Opdivo is PD-1 immune checkpoint inhibitor and is […]Read More